We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.19B
AUM Growth
+$8.49M
Cap. Flow
-$236M
Cap. Flow %
-5.63%
Top 10 Hldgs %
9.13%
Holding
691
New
49
Increased
226
Reduced
294
Closed
110

Top Buys

Rank Stock Value
1
G icon
Genpact
G
+$15.7M
2
SN icon
SharkNinja
SN
+$10.3M
3
COLD icon
Americold
COLD
+$8.79M
4
MRCY icon
Mercury Systems
MRCY
+$8.73M
5
OSBC icon
Old Second Bancorp
OSBC
+$7.85M

Sector Composition

Rank Sector Weight
1 Financials 20.3%
2 Industrials 19.06%
3 Healthcare 16.19%
4 Technology 14.12%
5 Consumer Discretionary 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JBSS icon
351
John B. Sanfilippo & Son
JBSS
$965M
$3.43M 0.08%
54,300
+3,911
+8% +$251K
VBNK
352
VersaBank
VBNK
$613M
$3.4M 0.08%
298,220
-94,130
-24% -$1.03M
BGC icon
353
BGC Group
BGC
$4.86B
$3.39M 0.08%
331,007
+5,506
+2% +$50.6K
PBYI icon
354
Puma Biotechnology
PBYI
$442M
$3.39M 0.08%
987,001
+75,878
+8% +$242K
PB icon
355
Prosperity Bancshares
PB
$8.81B
$3.32M 0.08%
+47,290
New +$3.26M
EWTX icon
356
Edgewise Therapeutics
EWTX
$4.84B
$3.31M 0.08%
252,524
+27,824
+12% +$401K
EXAS
357
DELISTED
Exact Sciences
EXAS
$3.31M 0.08%
62,249
-18,619
-23% -$946K
AZN icon
358
AstraZeneca
AZN
$251B
$3.3M 0.08%
23,647
-928
-4% -$130K
APGE icon
359
Apogee Therapeutics
APGE
$10.2B
$3.3M 0.08%
75,897
-2,500
-3% -$95.1K
NRIM icon
360
Northrim BanCorp
NRIM
$588M
$3.29M 0.08%
141,308
+7,780
+6% +$162K
GBFH
361
GBank Financial Holdings
GBFH
$302M
$3.27M 0.08%
+92,351
New +$3.62M
BCAL icon
362
Southern California Bancorp
BCAL
$687M
$3.24M 0.08%
205,394
+106,405
+107% +$1.52M
CVGW
363
DELISTED
Calavo Growers
CVGW
$3.23M 0.08%
121,609
+40,454
+50% +$1.06M
ASND icon
364
Ascendis Pharma A/S
ASND
$16.8B
$3.22M 0.08%
18,628
+16,078
+631% +$2.62M
OSPN icon
365
OneSpan
OSPN
$603M
$3.18M 0.08%
190,666
-54,483
-22% -$846K
DSGX icon
366
Descartes Systems
DSGX
$6.86B
$3.18M 0.08%
31,258
-1,742
-5% -$184K
HAPN
367
Happen Inc
HAPN
$2.24B
$3.15M 0.08%
261,709
+19,597
+8% +$204K
TRMB icon
368
Trimble
TRMB
$13.6B
$3.11M 0.07%
40,917
-2,274
-5% -$153K
PSN icon
369
Parsons
PSN
$4.93B
$3.1M 0.07%
+43,261
New +$2.86M
EWBC icon
370
East-West Bancorp
EWBC
$18.1B
$3.06M 0.07%
30,254
-1,683
-5% -$149K
BPOP icon
371
Popular Inc
BPOP
$11.1B
$3.04M 0.07%
+27,562
New +$2.72M
SYK icon
372
Stryker
SYK
$133B
$3.03M 0.07%
7,657
-1,116
-13% -$417K
EPC icon
373
Edgewell Personal Care
EPC
$1.29B
$2.99M 0.07%
127,725
+9,566
+8% +$265K
PRAX icon
374
Praxis Precision Medicines
PRAX
$10.2B
$2.96M 0.07%
70,445
+5,180
+8% +$197K
HLX icon
375
Helix Energy Solutions
HLX
$1.47B
$2.95M 0.07%
472,795
-99,778
-17% -$661K

Similar funds

Kennedy Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Kennedy Capital Management held 691 positions worth $4.19B, up 0.2% from $4.19B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Kennedy Capital Management withdrew a net $236M in Q2 2025, closing 110 positions and reducing 294 holdings. Its most notable exit was Columbia Banking Systems, an estimated $14.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Kennedy Capital Management opened a new position in Genpact worth $15.3M.

  • Kennedy Capital Management's largest Q2 2025 buy was Genpact: 347,353 shares worth $15.3M.
  • Kennedy Capital Management added most to Mercury Systems in Q2 2025, an estimated $8.73M increase.
  • Kennedy Capital Management's biggest Q2 2025 reduction was Hexcel, cutting an estimated $21.3M.
  • Kennedy Capital Management fully exited Columbia Banking Systems in Q2 2025, selling an estimated $14.4M.
  • Kennedy Capital Management's ten largest holdings make up 9.1% of its $4.19B portfolio in Q2 2025.
  • Kennedy Capital Management opened 49 new positions and closed 110 in Q2 2025.
  • Kennedy Capital Management's portfolio value rose 0.2% quarter-over-quarter to $4.19B.

Based on Kennedy Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.